诚信健康 ELV
$425.62 −$6.38 (-1.48%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $425.62 0.00%
开盘$421.47
昨收$432.00
当日区间$421.47 – $430.69
成交量1.44M
市值$91.96B
市盈率（TTM）18.1
股息率1.61%
ELV 相关新闻
匹配 Elevance Health 或代码 ELV 的头条新闻，按最新排序。
- Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488
- UBS Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $460
- Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $473
- UBS Group Employee Benefits Survey: Elevance Health (ELV.US) Leads as U.S. Employers Prepare for Rising Healthcare Costs 正面
- BofA Securities Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $480 正面
- Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $457
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX)
- RBC Capital Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $439 正面
- Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $488 正面
- Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404
- TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $465
- Leerink Partners Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $395 正面
- Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $450 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), Alnylam Pharma (ALNY) and Elevance Health (ELV)
- A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $393 to $475
暂无评论——快来第一个聊聊 ELV。
登录后参与讨论。